{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:41:20Z","timestamp":1787694080058,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s13277-015-4164-x","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T07:51:14Z","timestamp":1447401074000},"page":"5485-5492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study"],"prefix":"10.1007","volume":"37","author":[{"given":"Ming-zhu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,13]]},"reference":[{"issue":"11","key":"4164_CR1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson JK, Lindon JC, Holmes E. \u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29(11):1181\u20139.","journal-title":"Xenobiotica"},{"key":"4164_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","volume":"48","author":"O Fiehn","year":"2002","unstructured":"Fiehn O. Metabolomics\u2014the link between genotypes and phenotypes. Plant Mol Biol. 2002;48:155\u201371.","journal-title":"Plant Mol Biol"},{"key":"4164_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11306-005-1108-2","volume":"1","author":"W Welthagen","year":"2005","unstructured":"Welthagen W, Shellie R, Ristow M, Spranger J, Zimmermann R, Fiehn O. Comprehensive two dimensional gas chromatography-time of flight mass spectrometry, GCxGC-TOF for high resolution metabolomics: biomarker discovery on spleen tissue extracts of obese NZO compared to lean C57BL\/6 mice. Metabolomics. 2005;1:57\u201365.","journal-title":"Metabolomics"},{"issue":"24","key":"4164_CR4","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1002\/jssc.201100333","volume":"34","author":"X Wang","year":"2011","unstructured":"Wang X, Sun H, Zhang A, Wang P, Han Y. Ultra-performance liquid chromatography coupled to mass spectrometry as a sensitive and powerful technology for metabolomic studies. J Sep Sci. 2011;34(24):3451\u20139. Review.","journal-title":"J Sep Sci"},{"issue":"9","key":"4164_CR5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.metabol.2013.04.003","volume":"62","author":"MJ Gouveia","year":"2013","unstructured":"Gouveia MJ, Brindley PJ, Santos LL, da Costa JM C, Gomes P, Vale N. Mass spectrometry techniques in the survey of steroid metabolites as potential disease biomarkers: a review. Metabolism. 2013;62(9):1206\u201317.","journal-title":"Metabolism"},{"key":"4164_CR6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ijc.20651","volume":"113","author":"K Odunsi","year":"2005","unstructured":"Odunsi K, Wollman RM, Ambrosome CB, Hutson A, McCann SE, Tammela J, et al. Detection of epithelial ovarian cancer using H-1-NMR-based metabonomics. Int J Cancer. 2005;113:782\u20138.","journal-title":"Int J Cancer"},{"issue":"23","key":"4164_CR7","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-10-1434","volume":"16","author":"CM Slupsky","year":"2010","unstructured":"Slupsky CM, Steed H, Wells TH, Dabbs K, Schepansky A, Capstick V, et al. Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers. Clin Cancer Res. 2010;16(23):5835\u201341.","journal-title":"Clin Cancer Res"},{"issue":"7231","key":"4164_CR8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/457799a","volume":"457","author":"C Abate-Shen","year":"2009","unstructured":"Abate-Shen C, Shen MM. Diagnostics. The prostate-cancer metabolome. Nature. 2009;457(7231):799\u2013800.","journal-title":"Nature"},{"issue":"6","key":"4164_CR9","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1021\/pr901173v","volume":"9","author":"KK Pasikanti","year":"2010","unstructured":"Pasikanti KK, Esuvaranathan K, Ho PC, Mahendran R, Kamaraj R, Wu QH, et al. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J Proteome Res. 2010;9(6):2988\u201395.","journal-title":"J Proteome Res"},{"issue":"1","key":"4164_CR10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/pr3009572","volume":"12","author":"T Zhang","year":"2013","unstructured":"Zhang T, Wu X, Ke C, Yin M, Li Z, Fan L, et al. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling. J Proteome Res. 2013;12(1):505\u201312.","journal-title":"J Proteome Res"},{"issue":"8","key":"4164_CR11","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1039\/C4MB00054D","volume":"10","author":"Y Hou","year":"2014","unstructured":"Hou Y, Yin M, Sun F, Zhang T, Zhou X, Li H, et al. A metabolomics approach for predicting the response to neoadjuvant chemotherapy in cervical cancer patients. Mol Biosyst. 2014;10(8):2126\u201333.","journal-title":"Mol Biosyst"},{"issue":"1","key":"4164_CR12","first-page":"92","volume":"21","author":"M Yin","year":"2011","unstructured":"Yin M, Zhao F, Lou G, Zhang H, Sun M, Li C, et al. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer. 2011;21(1):92\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"4164_CR13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jso.22052","volume":"105","author":"M Yin","year":"2012","unstructured":"Yin M, Zhang H, Li H, Li X, Liu Y, Chen X, et al. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer. J Surg Oncol. 2012;105(2):206\u201311.","journal-title":"J Surg Oncol"},{"issue":"3","key":"4164_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1470-2045(09)70191-3","volume":"11","author":"L Rob","year":"2010","unstructured":"Rob L, Halaska M, Robova H. Nerve-sparing and individually tailored surgery for cervical cancer. Lancet Oncol. 2010;11(3):292\u2013301. Review.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4164_CR15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1021\/pr901130s","volume":"9","author":"HM Lin","year":"2010","unstructured":"Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, et al. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn\u2019s disease. J Proteome Res. 2010;9(4):1965\u201375.","journal-title":"J Proteome Res"},{"issue":"1","key":"4164_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.aca.2009.02.027","volume":"650","author":"J Zhang","year":"2009","unstructured":"Zhang J, Yan L, Chen W, Lin L, Song X, Yan X, et al. Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Anal Chim Acta. 2009;650(1):16\u201322.","journal-title":"Anal Chim Acta"},{"key":"4164_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29\u201336.","journal-title":"Radiology"},{"key":"4164_CR18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/nar\/gkn810","volume":"37","author":"DS Wishart","year":"2009","unstructured":"Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009;37:603\u201310.","journal-title":"Nucleic Acids Res"},{"key":"4164_CR19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","volume":"27","author":"CA Smith","year":"2005","unstructured":"Smith CA, Maille OG, Want EJ, Qin C, Trauger SA, Brandon TR, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit. 2005;27:747\u201351.","journal-title":"Ther Drug Monit"},{"issue":"21","key":"4164_CR20","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","volume":"66","author":"S Kjaer","year":"2006","unstructured":"Kjaer S, Hodall E, Frederiksen K, Munk C, van den Brule A, Svare E, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res. 2006;66(21):10630\u20136.","journal-title":"Cancer Res"},{"key":"4164_CR21","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1073\/pnas.90.11.4917","volume":"90","author":"Y Asaoka","year":"1993","unstructured":"Asaoka Y, Yoshida K, Sasaki Y, Nishizuka Y. Potential role of phospholipase A2 in HL-60 cell differentiation to macrophages induced by protein kinase C activation. Proc nat Acad Sci (Wash). 1993;90:4917\u201321.","journal-title":"Proc nat Acad Sci (Wash)"},{"key":"4164_CR22","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1073\/pnas.89.14.6443","volume":"89","author":"K Yoshida","year":"1992","unstructured":"Yoshida K, Asaoka Y, Nishizuka Y. Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acids. Proc nat Acad Sci (Wash). 1992;89:6443\u20136.","journal-title":"Proc nat Acad Sci (Wash)"},{"key":"4164_CR23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U","volume":"12","author":"F Podo","year":"1999","unstructured":"Podo F. Tumour phospholipid metabolism. Review article. NMR Biomed. 1999;12:413\u201339.","journal-title":"NMR Biomed"},{"key":"4164_CR24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/157340507780619160","volume":"3","author":"F Podo","year":"2007","unstructured":"Podo F, Sardanelli F, Iorio E, Canese R, Carpinelli G, Alfonso F. Abnormal choline phospholipid metabolism in breast and ovary cancer: molecular bases for noninvasive imaging approaches. Curr Mol Imag Rev. 2007;3:123\u201337.","journal-title":"Curr Mol Imag Rev"},{"key":"4164_CR25","first-page":"3599","volume":"61","author":"E Ackerstaff","year":"2001","unstructured":"Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res. 2001;61:3599\u2013603.","journal-title":"Cancer Res"},{"key":"4164_CR26","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1158\/0008-5472.CAN-05-1146","volume":"65","author":"E Iorio","year":"2005","unstructured":"Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D\u2019Ascenzo S, et al. Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res. 2005;65:9369\u201376.","journal-title":"Cancer Res"},{"key":"4164_CR27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp060067e","volume":"3","author":"K Glunde","year":"2006","unstructured":"Glunde K, Ackerstaff E, Mori N, Jacobs MA, Bhujwalla ZM. Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm. 2006;3:496\u2013506.","journal-title":"Mol Pharm"},{"key":"4164_CR28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2217\/14622416.7.7.1109","volume":"7","author":"K Lunde","year":"2006","unstructured":"Lunde K, Serkova NJ. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics. 2006;7:1109\u201323.","journal-title":"Pharmacogenomics"},{"issue":"1","key":"4164_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4","volume":"71","author":"M Okita","year":"1997","unstructured":"Okita M, Gaudette DC, Mills GB, Holub BJ. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine (lysoPC) in ovarian cancer patients. Int J Cancer. 1997;71(1):31\u20134.","journal-title":"Int J Cancer"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4164-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4164-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T11:43:37Z","timestamp":1559475817000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4164-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,13]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["4164"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4164-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,13]]}}}